A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome

C De Giovanni1, G Nicoletti, A Palladini

  • 1Cancer Research Section, Department of Experimental Pathology, Alma Mater Studiorum, University of Bologna, I-40126 Bologna, Italy. carla.degiovanni@unibo.it

Human Gene Therapy
|February 14, 2009
PubMed

Insights

A novel DNA-based cancer vaccine (Tri-DNA) effectively prevents aggressive cancers in mice. This vaccine, similar to an earlier cell-based version, offers protection by stimulating a targeted immune response against cancer cells.

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Female mice with p53 knockout and HER-2/neu (Neu) transgene develop aggressive cancer.
  • A previous Triplex cell vaccine, combining Neu, IL-12, and MHC, prevented this cancer.
  • A second-generation DNA-based vaccine (Tri-DNA) was developed for improved cancer immunoprevention.

Purpose of the Study:

  • To evaluate the efficacy of the Tri-DNA vaccine compared to the Triplex cell vaccine.
  • To analyze the immune response induced by the Tri-DNA vaccine.
  • To assess the potential of Tri-DNA for cancer immunoprevention.

Main Methods:

  • Developed a Tri-DNA vaccine with Neu, IL-12, and H-2D(q) MHC genes on separate plasmids.
  • Administered Tri-DNA vaccine to BALB-p53Neu mice.
  • Assessed cancer onset, survival rates, and immune responses (antibody isotypes, cytokine profiles).

Main Results:

  • Tri-DNA vaccine demonstrated efficacy comparable to the Triplex cell vaccine.
  • Both vaccines delayed mammary cancer onset and completely prevented salivary cancer.
  • Tri-DNA induced a Th1-polarized immune response with IFN-gamma production and anti-Neu IgG2a antibodies.
  • Triplex cell vaccine induced both Th1 and Th2 responses, increased spontaneous IFN-gamma, and IgG3 antibodies.

Conclusions:

  • The Tri-DNA vaccine is as effective as the Triplex cell vaccine for cancer immunoprevention.
  • Tri-DNA elicits a more restricted, Th1-biased immune stimulation.
  • This suggests Tri-DNA is a promising alternative for cancer vaccine development.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...